Together for Hope: METAvivor x Ageless Zen
June 5, 2025
BY Kelly Shanahan, M.D. “As a mom, as a doctor, and now as an advocate for and a person living with metastatic breast cancer, I’ve
Explore updates on metastatic breast cancer research, hear from the MBC community, and learn how your support is making a difference.
BY Kelly Shanahan, M.D. “As a mom, as a doctor, and now as an advocate for and a person living with metastatic breast cancer, I’ve
BY Kelly Shanahan, M.D. METAvivor President and Director of Research Phew, it’s been a crazy start to 2025 but we’ve hit the ground running
BY Kelly Shanahan, M.D. METAvivor President and Director of Research METAvivor’s core mission is to fund research that will benefit those of us whose cancer
We’re thrilled to share exciting news from METAvivor: we have received 195 Letters of Intent (LOIs) for our 2025 metastatic breast cancer (MBC) research grant cycle — nearly double
BY Gloria Echeverria, PhD Feb 25, 2025 Note: These views are my own and do not necessarily represent those of my current employer, Baylor College
On behalf of the METAvivor Board of Directors, we are incredibly grateful for your continued support, which has enabled life-changing research. Thanks to you, we’ve
Advocate for yourself! HHS must be allowed to function Background: METAvivor is deeply concerned about the unintended consequences of the recent directive halting external communications
METAvivor is excited to announce the newest additions to our Executive Committee, who bring a wealth of expertise, passion, and commitment to advancing our mission.
BY METAvivor An MBC thriver, Cassie Romano, recently published a book: What To Expect When You Weren’t Expecting Metastatic Breast Cancer. She writes: Our book is
BY METAvivor METAvivor Research and Support announces 13 new grant awards to research investigators for metastatic breast cancer research totaling $4.6 million. Metastatic or stage
METAvivor Research and Support announces 12 new grant awards to research investigators for metastatic breast cancer research totaling $3.75 million. Metastatic, or stage IV, breast
BY Jamil Rivers, President, METAvivor and Sonya Negley, Executive Director From Jamil: As we mourn the loss of one of our most ardent supporters and